Literature DB >> 19653134

Epigenetics lessons from twins: prospects for autoimmune disease.

Esteban Ballestar1.   

Abstract

The existence of phenotypic differences between monozygotic (MZ) twins is a prime case where the relationship between genetic determinants and environmental factors is illustrated. Although virtually identical from a genetic point of view, MZ twins show a variable degree of discordance with respect to different features including susceptibility to disease. Discordance has frequently been interpreted in terms of the impact of the environment with genetics. In this sense, accumulated evidence supports the notion that environmental factors can have a long-term effect on epigenetic profiles and influence the susceptibility to disease. In relation with autoimmune diseases, the identification of DNA methylation changes in individuals who develop the disease, and the influence of inhibitors of DNA methyltransferases and histone modification enzymes in the development of autoimmunity are attracting the attention of researchers in the epigenetics field. In this context, the study of discordant MZ twins constitutes an attractive model to further investigate the epigenetic mechanisms involved in their development as well as to dissect the contribution of environmental traits. The implications of novel strategies to map epigenetic profiles and how the use of MZ twins can contribute to dissect the epigenetic component of autoimmune disease are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19653134     DOI: 10.1007/s12016-009-8168-4

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  96 in total

1.  Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly.

Authors:  J Nakayama ; J C Rice; B D Strahl; C D Allis; S I Grewal
Journal:  Science       Date:  2001-03-15       Impact factor: 47.728

Review 2.  Incidental neurodevelopmental episodes in the etiology of schizophrenia: an expanded model involving epigenetics and development.

Authors:  S M Singh; P McDonald; B Murphy; R O'Reilly
Journal:  Clin Genet       Date:  2004-06       Impact factor: 4.438

3.  Increased DNA methylation at the AXIN1 gene in a monozygotic twin from a pair discordant for a caudal duplication anomaly.

Authors:  N A Oates; J van Vliet; D L Duffy; H Y Kroes; N G Martin; D I Boomsma; M Campbell; M G Coulthard; E Whitelaw; S Chong
Journal:  Am J Hum Genet       Date:  2006-05-22       Impact factor: 11.025

4.  Cohort profile: the Dutch Hunger Winter families study.

Authors:  L H Lumey; Aryeh D Stein; Henry S Kahn; Karin M van der Pal-de Bruin; G J Blauw; Patricia A Zybert; Ezra S Susser
Journal:  Int J Epidemiol       Date:  2007-06-25       Impact factor: 7.196

Review 5.  Nuclear receptors: one big family.

Authors:  Iain J McEwan
Journal:  Methods Mol Biol       Date:  2009

6.  Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  B Richardson; L Scheinbart; J Strahler; L Gross; S Hanash; M Johnson
Journal:  Arthritis Rheum       Date:  1990-11

Review 7.  Leukemia in twins: lessons in natural history.

Authors:  Mel F Greaves; Ana Teresa Maia; Joseph L Wiemels; Anthony M Ford
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

8.  Differential expression of a new dominant agouti allele (Aiapy) is correlated with methylation state and is influenced by parental lineage.

Authors:  E J Michaud; M J van Vugt; S J Bultman; H O Sweet; M T Davisson; R P Woychik
Journal:  Genes Dev       Date:  1994-06-15       Impact factor: 11.361

9.  Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus.

Authors:  Qianjin Lu; Mariana Kaplan; Donna Ray; Doreen Ray; Sima Zacharek; David Gutsch; Bruce Richardson
Journal:  Arthritis Rheum       Date:  2002-05

10.  Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance?

Authors:  Arturas Petronis; Irving I Gottesman; Peixiang Kan; James L Kennedy; Vincenzo S Basile; Andrew D Paterson; Violeta Popendikyte
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

View more
  37 in total

Review 1.  The therapeutic potential of epigenetics in autoimmune diseases.

Authors:  Maria De Santis; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

Review 2.  The epigenetics of autoimmunity.

Authors:  Francesca Meda; Marco Folci; Andrea Baccarelli; Carlo Selmi
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 3.  Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes.

Authors:  Birgit Knoechel; Jens G Lohr
Journal:  J Autoimmun       Date:  2013-07-21       Impact factor: 7.094

Review 4.  Epigenetics of multiple sclerosis: an updated review.

Authors:  Cem İsmail Küçükali; Murat Kürtüncü; Arzu Çoban; Merve Çebi; Erdem Tüzün
Journal:  Neuromolecular Med       Date:  2014-03-21       Impact factor: 3.843

Review 5.  Immune senescence, epigenetics and autoimmunity.

Authors:  Donna Ray; Raymond Yung
Journal:  Clin Immunol       Date:  2018-04-11       Impact factor: 3.969

6.  Novel challenges for the allergist.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

7.  Cutting-edge issues in organ-specific autoimmunity.

Authors:  M Eric Gershwin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 8.  Epigenetics and the transition from acute to chronic pain.

Authors:  Thomas Buchheit; Thomas Van de Ven; Andrew Shaw
Journal:  Pain Med       Date:  2012-09-14       Impact factor: 3.750

9.  Demethylation of the human eotaxin-3 gene promoter leads to the elevated expression of eotaxin-3.

Authors:  Eunjin Lim; Marc E Rothenberg
Journal:  J Immunol       Date:  2013-12-09       Impact factor: 5.422

Review 10.  The fate is not always written in the genes: epigenomics in epidemiologic studies.

Authors:  Scott M Langevin; Karl T Kelsey
Journal:  Environ Mol Mutagen       Date:  2013-02-26       Impact factor: 3.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.